UCP2 and acute lymphoblastic leukemia: Interestingly, while no significant change in the OCR/ECAR ratio was observed in Jurkat cells after UCP2 silencing whatever the culture conditions, a massive decrease in this metabolic ratio was observed in UCP2CRISPR HPB-ALL cells (Figure 4D).